• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠和大鼠原癌基因mas在脑和外周组织中的表达。

Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues.

作者信息

Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, Ganten D

机构信息

German Institute for High Blood Pressure Research, Heidelberg.

出版信息

FEBS Lett. 1995 Jan 2;357(1):27-32. doi: 10.1016/0014-5793(94)01292-9.

DOI:10.1016/0014-5793(94)01292-9
PMID:8001672
Abstract

We isolated the mas proto-oncogene from a mouse genomic library. Sequence analysis showed that it contains an open reading frame without intervening sequences. The amino acid sequence deduced confirms the seven-transmembrane-domain structure and exhibits 97% and 91% amino acid homology with the rat and the human Mas, respectively. In mice and rats, mas mRNA was detected in the testis, kidney, heart, and in the brain regions: hippocampus, forebrain, piriform cortex, and olfactory bulb. Testicular mas mRNA from rats increases markedly during development, while cerebellar mRNA is high postnatally but completely disappears at later stages. We conclude that the product of the mouse mas gene may be involved in the development of the brain and testis.

摘要

我们从小鼠基因组文库中分离出原癌基因mas。序列分析表明,它包含一个没有间隔序列的开放阅读框。推导的氨基酸序列证实了七跨膜结构域结构,并且分别与大鼠和人类的Mas具有97%和91%的氨基酸同源性。在小鼠和大鼠中,在睾丸、肾脏、心脏以及脑区:海马体、前脑、梨状皮质和嗅球中检测到mas mRNA。大鼠睾丸中的mas mRNA在发育过程中显著增加,而小脑mRNA在出生后较高,但在后期完全消失。我们得出结论,小鼠mas基因的产物可能参与大脑和睾丸的发育。

相似文献

1
Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues.小鼠和大鼠原癌基因mas在脑和外周组织中的表达。
FEBS Lett. 1995 Jan 2;357(1):27-32. doi: 10.1016/0014-5793(94)01292-9.
2
Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain.大鼠mas癌基因的特性及其在大鼠脑海马体和大脑皮层中的高表达
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5339-42. doi: 10.1073/pnas.85.14.5339.
3
Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis.编码在脑和睾丸中表达的孤儿G蛋白偶联肽受体的小鼠Gpr37基因的分子克隆及染色体定位。
Genomics. 1998 Nov 1;53(3):315-24. doi: 10.1006/geno.1998.5433.
4
Molecular cloning and characterization of murine and human N-acetylglucosamine kinase.小鼠和人N-乙酰葡糖胺激酶的分子克隆与特性分析
Eur J Biochem. 2000 Jun;267(11):3301-8. doi: 10.1046/j.1432-1327.2000.01360.x.
5
Characterization of the mouse Men1 gene and its expression during development.小鼠Men1基因的特征及其在发育过程中的表达。
Oncogene. 1998 Nov 12;17(19):2485-93. doi: 10.1038/sj.onc.1202164.
6
Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization.
Neurosci Lett. 1990 Jul 3;114(2):147-53. doi: 10.1016/0304-3940(90)90063-f.
7
Purification, cDNA cloning, and developmental changes in the steady-state mRNA level of rat testicular tissue inhibitor of metalloproteases-2 (TIMP-2).大鼠睾丸组织金属蛋白酶抑制剂2(TIMP-2)的纯化、cDNA克隆及稳态mRNA水平的发育变化
J Androl. 1996 May-Jun;17(3):263-75.
8
Cell type-specific expression of the Mas proto-oncogene in testis.Mas原癌基因在睾丸中的细胞类型特异性表达。
J Histochem Cytochem. 2002 May;50(5):691-6. doi: 10.1177/002215540205000510.
9
Isolation and developmental expression of a rat cDNA encoding a cysteine-rich zinc finger protein.编码富含半胱氨酸锌指蛋白的大鼠cDNA的分离与发育表达
Nucleic Acids Res. 1994 Dec 11;22(24):5477-83. doi: 10.1093/nar/22.24.5477.
10
Molecular cloning and expression analysis of a mouse phospholipase C-delta1.小鼠磷脂酶C-δ1的分子克隆与表达分析
Biochem Biophys Res Commun. 1999 Aug 2;261(2):393-9. doi: 10.1006/bbrc.1999.1035.

引用本文的文献

1
Angiotensin-(1-7) and Central Control of Cardiometabolic Outcomes: Implications for Obesity Hypertension.血管紧张素 -(1 - 7)与心脏代谢结局的中枢控制:对肥胖高血压的影响
Int J Mol Sci. 2024 Dec 12;25(24):13320. doi: 10.3390/ijms252413320.
2
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.Mas 受体:缺血性心血管疾病治疗的潜在策略。
Cell Cycle. 2023 Jul;22(13):1654-1674. doi: 10.1080/15384101.2023.2228089. Epub 2023 Jun 26.
3
Sex Difference in MasR Expression and Functions in the Renal System.
性别差异在肾脏系统中的 MasR 表达和功能。
J Renin Angiotensin Aldosterone Syst. 2022 Sep 10;2022:1327839. doi: 10.1155/2022/1327839. eCollection 2022.
4
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences.血管紧张素转换酶2/血管紧张素1-7轴在严重新型冠状病毒肺炎后果形成中的作用
Pharmaceutics. 2022 Sep 8;14(9):1906. doi: 10.3390/pharmaceutics14091906.
5
Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives.肾素-血管紧张素系统在应激中的作用:最新研究进展和研究展望。
Curr Neuropharmacol. 2022;20(6):1212-1228. doi: 10.2174/1570159X19666210719142300.
6
Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.血脑屏障穿越肾素-血管紧张素药物与老年人认知:一项荟萃分析。
Hypertension. 2021 Sep;78(3):629-643. doi: 10.1161/HYPERTENSIONAHA.121.17049. Epub 2021 Jun 21.
7
Chronic administration of pharmacological doses of angiotensin 1-7 and iodoangiotensin 1-7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats.血管紧张素 1-7 和碘代血管紧张素 1-7 的药理剂量的慢性给药对自发性高血压大鼠的血压、心率和认知功能几乎没有影响。
Physiol Rep. 2021 Apr;9(7):e14812. doi: 10.14814/phy2.14812.
8
Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!肾素-血管紧张素-醛固酮系统调节在糖尿病肾病中的潜力:旧有靶点带来新希望!
Rev Physiol Biochem Pharmacol. 2021;179:31-71. doi: 10.1007/112_2020_50.
9
Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.新冠疫情对男性生育力是否有影响?ACE2 的关联。
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E878-E880. doi: 10.1152/ajpendo.00183.2020. Epub 2020 May 18.
10
The Renin-Angiotensin System in Huntington's Disease: Villain or Hero?亨廷顿舞蹈病中的肾素-血管紧张素系统:反派还是英雄?
Protein Pept Lett. 2020;27(6):456-462. doi: 10.2174/0929866527666200110154523.